Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
GI Eosinophilic Disorders
•
Primary Care
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Answer from: at Community Practice
I would do the higher dose (EoE) if starting it for both.
Sign In
or
Register
to read more
23638
Related Questions
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What therapies would be considered safe and effective in pregnant patients with EoE?
How do you counsel parents about the anticipated abdominal pain associated with oral desensitization in peanut-allergic children?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
What signs and symptoms in a patient are you having GI evaluate for an EGID?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
For patients with progessive CKD with comorbid conditions, do you adjust IVIG or switch to SCIG to prevent further progession in GFR reduction?
What is your approach to biologic selection in a patient with resistant/persistent ABPA?
In a pregnant patient with scarring alopecia (LPP or CCCA), what treatment options are available?